Condition
Genetic Condition
Total Trials
4
Recruiting
1
Active
1
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 87/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
67% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 2 (1)
Trial Status
Completed2
Terminated1
Recruiting1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07073378Not ApplicableRecruiting
BCI@Home: Brain Computer Interface Solutions to Enable Youth Living With Severe Disabilities
NCT06671704Not ApplicableCompleted
GC-PRO Intervention
NCT03683277Phase 2Terminated
IPD in RRMM Characterized with Genomic Abnormalities of Adverse Prognostic
NCT03708991CompletedPrimary
Effectiveness of PGT-A: IVF Versus ICSI
Showing all 4 trials